DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 4Dr. Reddy's Laboratories
02 1Pharmathen SA
03 4Accord healthcare
04 1Activo Health
05 1Akorn Pharmaceuticals
06 1Aurobindo Pharma Limited
07 1Austell Laboratories
08 2Avet Pharmaceuticals
09 2Avyxa
10 1Baxter Healthcare Corporation
11 1Biem Ilac San. ve Tic. A.S
12 1Chartwell Pharmaceuticals llc
13 1Cipla
14 2Dr Reddy's Laboratories (Australia) Pty Ltd
15 2Eurolab
16 4Farbe Firma
17 1Farmatek
18 1Fresenius Kabi AB Brunna
19 3Fresenius Kabi USA
20 1Fresenius SE & Co. KGaA
21 2Hangzhou Jiuyuan Gene Engineering
22 15Helsinn Advanced Synthesis
23 1Hikma Pharmaceuticals
24 2Hospira, Inc.
25 1Jiangsu Hengrui Medicine
26 2Juniper Biologics
27 2Knight Therapeutics
28 1Labatec Pharm
29 4Medius AG
30 2Medsurge Healthcare
31 1Meitheal Pharmaceuticals
32 1Novast Laboratories
33 1ORIFARM GROUP AS
34 1Pharmada Pharmaceuticals
35 1Polifarma
36 2Qilu Pharmaceutical
37 2Sagent Pharmaceuticals
38 3Samyang Biopharmaceuticals
39 2Sandoz B2B
40 1Tecnimede
41 4Teva Pharmaceutical Industries
42 2TherDose Pharma
43 1Viatris
44 1Yangtze River Pharmaceutical Group
01 1CAPSULE
02 2CAPSULE;ORAL
03 1Caps
04 1Capsule
05 1Capsule, hard
06 2Capsule, soft
07 1Hard Capsule
08 6INJ
09 1INJECTABLE;INJECTION
10 25INJECTABLE;INTRAVENOUS
11 1IV Injection Solution
12 1Inf Conc
13 5Inj L?s
14 1Injectable Solution
15 12Injection
16 3Injection fluid, resolution
17 1Kaps
18 2Kapsel, hard
19 3Liquid Injection
20 1Netupitant+Palonosetron 0,5+300Mg 1 Combined Oral Use
21 1POWDER;INTRAVENOUS
22 1Palonosetron 250Mcg 5Ml 1 Units Parenteral Use
23 1SOFT CAPSULE
24 1SOLUTION
25 1SOLUTION FOR INJECTION
26 5SOLUTION;INTRAVENOUS
27 1Solution for I.V. Injection
28 1Solution for IV Injection
29 1Solution for Injection
30 6Blank
01 14DISCN
02 5Generic
03 2Lead Market Dossiers- Filed
04 2Originator
05 2Prescription
06 19RX
07 1USA
08 45Blank
01 4AKYNZEO
02 4ALOXI
03 6Akynzeo
04 1Akynzeo IV
05 10Aloxi
06 1Kemoprev IV
07 1Onicit
08 2PALIBOUT
09 3PALONOSETRON
10 1PALONOSETRON 0.05mg/ml FRESENIUS
11 1PALONOSETRON 0.25 TEVA
12 26PALONOSETRON HYDROCHLORIDE
13 2PALONOSETRON Medsurge
14 2POSFREA
15 1Palcita
16 2Palonosetron Accord
17 2Palonosetron Dr.Reddy's
18 1Palonosetron Fresenius Kabi
19 1Palonosetron Labatec
20 1Palonosetron Sandoz
21 1Palonosetron-Teva
22 1Paloxitron
23 1Palton
24 1Votron
25 14Blank
01 6Australia
02 2Canada
03 4China
04 1Greece
05 8India
06 2Italy
07 8Norway
08 1Portugal
09 7South Africa
10 3South Korea
11 2Sweden
12 8Switzerland
13 4Turkey
14 34USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-04-21
Application Number : 201533
Regulatory Info : DISCN
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : USA
Registration Country : Greece
Brand Name :
Dosage Form : Hard Capsule
Dosage Strength : 300; 0.5
Packaging :
Approval Date :
Application Number :
Regulatory Info : USA
Registration Country : Greece
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-04-21
Application Number : 201533
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 0.075MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 0.25MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-03-15
Application Number : 204615
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 0.25MG(BASE)/5ML
Packaging :
Approval Date :
Application Number : 204731
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-11-06
Application Number : 204702
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-06-29
Application Number : 202951
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2021-06-29
Application Number : 202951
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POSFREA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-03-01
Application Number : 203050
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POSFREA
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2016-03-01
Application Number : 203050
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2003-07-25
Application Number : 21372
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-02-29
Application Number : 21372
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : ALOXI
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 0.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-08-22
Application Number : 22233
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 205648
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-09-19
Application Number : 204289
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2015-10-13
Application Number : 202521
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-03-23
Application Number : 90713
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : PALONOSETRON HYDROCHLORIDE
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML)
Packaging :
Approval Date : 2018-03-23
Application Number : 90713
Regulatory Info : DISCN
Registration Country : USA
LOOKING FOR A SUPPLIER?
